DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING ISOCRATIC REVERSE PHASE-LIQUID CHROMATOGRAPHY ASSAY FOR DETERMINATION OF PHENYTOIN IN BULK AND PHARMACEUTICAL FORMULATIONS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 8
Abstract
Objective: To develop and validate a stability-indicating reversed phase high performance liquid chromatography (RP-HPLC) assay for the determination of phenytoin in bulk and pharmaceutical dosage forms.Methods: A HPLC instrument incorporating aZorbaxC-18 analytical column (250x4.6 mm, 5μm particles) with a mobile phase comprising acetonitrile: water in the ratio 50:50 (%v/v) was employed for the determination of phenytoin. The flow rate was set with an isocratic program, the temperature of the column was maintained at 25 °C and a detection wavelength of 200 nm was employed using an ultraviolet detector. The method was validated as per The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines.Results: Total chromatographic analysis time per sample was 6 min with phenytoin eluting with the reaction time of 4.6±0.2 min. Phenytoin was exposed to acidic, basic, oxidative, photolytic and thermal stress conditions and the specificity of the assay was confirmed. The calibration plot was linear(R2≥0.999) over the phenytoin concentration range 5.0-100.0μg/ml. The percentage means recoveries were found to be in the range of 98-102%. The relative standard deviation of precision and robustness were within prescribed limits (<2%). The limit of detection was 0.047 µg/ml while the limit of quantitation was established as 0.143 µg/ml.Conclusion: A simple, accurate, precise and stability-indicating RP-HPLC assay was successfully developed for the determination of phenytoin in bulk and dosage forms. Hence, this assay is useful for the analysis of phenytoin in formulations in medicines development and pharmaceutical manufacturing setting.Â
Authors and Affiliations
Siew Yong Teo, Michael J. Rathbone, Allan G. A. Coombes, Siang Yin Lee, Seng Neon Gan
Keywords
Related Articles
- EP ID EP578320
- DOI -
- Views 65
- Downloads 0
FLAVONOIDS FROM SUGAR BEET LEAVES AS HEPATOPROTECTIVE AGENT
Objective: This work was designed to investigate the activity of Beta vulgaris (B. vulgaris) extract against hepatotoxicity induced by (carbon tetrachloride) CC14 in male rats.Methods: Hepatoprotective study was performe...
SYNTHESIS OF TRIAZOLOTHIADIAZINE DERIVATIVES AS ANTIOXIDANT AGENTS
Objectives: The objective of the present study is to synthesize 3-substituted phenyl-6-phenyl-7H-[1, 2, 4] triazolo [3, 4-b][1,3,4] thiadiazine. The structures of all the synthesized compounds were characterized by IR, 1...
THE USE OF ASSISTIVE COUNSELLING TOOL “LUNG TB CARE” TO INCREASE PATIENT’S KNOWLEDGE LEVEL (A STUDY IN TUBERCULOSIS PATIENTS AT MALANG’S PRIMARY HEALTH CARE CENTERS)
Objective: Patient’s compliance in taking medication has an important role for the success of tuberculosis (TB) therapy because of long period of treatment. One of the reasons of frequent failure in tuberculosis the...
ANTIMICROBIAL ACTIVITY OF OLIGOMERIC β–DEFENSIN ISOLATED FROM HEART TISSUE OF CAPRA HIRCUS
Objective: The aim of the present study was to isolate an antimicrobial peptide from heart tissue of Capra hircus (Goat) and to check its antibacterial activity against antibiotic resistant and antibiotic sensitive bacte...
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC FOR DETERMINATION OF ATORVASTATIN CALCIUM and EZETIMIBE IN BULK AND PHARMACEUTICAL DOSAGE FORMS
Objective: A simple, speciï¬c, sensitive, accurate and precise stability indicating methods were described for the quantitative determination of the lipid-lowering agent drug Atorvastatin calcium and Ezetimibe.Methods:...